These threadsβdiagnostics, mechanistic science, emerging therapies, and lived experienceβare finally beginning to connect. A more coordinated future for rare disease care is taking shape.
Full version here: www.linkedin.com/feed/update/...
@ebiomedicine
Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of The Lancet Discovery Science. IF=10.8 π https://www.thelancet.com/journals/ebiom/home
These threadsβdiagnostics, mechanistic science, emerging therapies, and lived experienceβare finally beginning to connect. A more coordinated future for rare disease care is taking shape.
Full version here: www.linkedin.com/feed/update/...
π¬ Genomics is shortening diagnostic delays
𧬠IPSCs, organoids & CRISPR are transforming mechanistic insight
π Nucleicβacid therapeutics are moving from isolated N=1 efforts toward more coordinated national approaches
π§‘ Patients and families are essential partners shaping priorities and outcomes
π Ahead of #RareDiseaseDay, reflections from the 5th @crick.ac.uk Rare Disease Conference: although each rare condition affects few people, 300M+ individuals worldwide live with a rare disease. Delayed diagnosis, limited treatments, and fragmented care remain major challenges.
π§ Listen wherever you get your podcasts: open.spotify.com/show/37oRXtY...
πRead the reviews:
Sleep apnea, heart health and testosterone: www.thelancet.com/journals/EBI...
Why sleep matters in chronic pain: www.thelancet.com/journals/EBI...
π₯±π΄ Sleep matters: a new eBioMedicine series on sleep health unveils how sleep, cardiometabolic health, hormones, and pain intersect across the lifespan. The 2 open-access reviews highlight mechanisms, clinical implications, and opportunities for integrated care.
Published in @ebiomedicine.bsky.social
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion www.thelancet.com/journals/ebi...
non-functioning #adrenal #tumours
#Cushing's syndrome
#OpenAccess
#MedSky #EndoSky
β³ As interest in ageing clocks grows, we examine what it will take to move these tools from curiosity to credible clinical biomarkersβhighlighting advances in epigenetic clocks, key methodological gaps, and the path toward rigorous validation and clinical integration.
#AgeingResearch #Epigenetics
π¨ The February 2026 issue of eBioMedicine is now live.
This monthβs Editorial tackles a central question in longevity science and modern medicine:
Can biological age be measured in a way that meaningfully improves clinical care?
π All open access content here: www.thelancet.com/issue/S2352-...
People are living with disease while waiting for research to become care. The @britishneuro.bsky.social Festive Symposium highlighted that the ethical duty of translational neuroscience now extends beyond discovery itself. Delivery is part of the science.
π www.thelancet.com/journals/ebi...
π§ͺ Publication in @ebiomedicine.bsky.social, project led by @wiebkearlt.bsky.social @mrc-lms.bsky.social & A Prete @unibirmingham.bsky.social with important contributions from @rug.nl theses by @ariadnaalbors.bsky.social , E van den Brandhof, Y Zhang & L Visser
www.sciencedirect.com/science/arti...
π¦ #Hantavirus - How long does the immunity last after a Puumala #virus infection?
#MedUniVienna & @medunigraz.atβ investigated the immune responses elicited in Styrian Puumala virus patients.
π° @ebiomedicine.bsky.socialβ
Great overview of where the field stands on henipavirus host-pathogen interactions, and the experimental models helping us study them π§¬π¬ Well done @carroll-lab.bsky.social and teamπ
Worth a read π
π On the cover
βοΈ Editorial: Expanding intrathecal gene therapy for lysosomal storage diseases
π¨ First-in-human: High-dose AAV9 intrathecal gene therapy for paediatric CLN7
𧬠Research: Spatial transcriptomics links lipid metabolism to immuneβstromal crosstalk in SjΓΆgrenβs disease
eBioMedicine January 2026 cover. The cover depicts scientists on ladders and scaffolds working on a strand of DNA.
π’ Our first issue of 2026 is now live! The latest issue highlights cutting-edge research in gene therapy, immunology, neuroscience, and translational medicine.
π Read the full issue online
Genetic factors shaping the plasma lipidome and the relations to cardiometabolic risk in children and adolescents @dream-diabetes.bsky.social @ebiomedicine.bsky.social www.thelancet.com/journals/ebi...
Human lymph node, cross-section, artwork. Image copyright PIXOLOGICSTUDIO β Getty Images
A new study shows the immune systemβs first respondersβCD4+ Tfh cellsβrapidly activate in draining lymph nodes to drive strong flu vaccine protection across diverse populations πͺπ
@jqsiu.bsky.social and colleaguesβ work here: doi.org/10.1016/j.eb...
Find the paper in our December 2025 issue:
β‘οΈ doi.org/10.1016/j.eb...
Colorful pills and capsules on blue background. Image copyright Tania Ivanova β Getty Images.
There is a growing need for non-opioid pharmaceutical alternatives for effective chronic pain treatment
@laurahuckins.bsky.social @kjohnst9.bsky.social et al. developed a novel genetics-informed framework for drug repurposing, leveraging existing genetic and transcriptomic data resources ππ§¬
A mosquito is pictured in silhouette. The headline reads "First-in-class drug candidate offers hope in malaria fight"
A new study by WEHI and MSD researchers has unveiled a first-in-class antimalarial drug candidate that targets two essential parasite enzymes across multiple life stages.
Published in @ebiomedicine.bsky.social
www.wehi.edu.au/news/new-ant...
Thrilled to share our paper is out now in @ebiomedicine.bsky.social π₯³ The interoception accuracy part is still my favorite π€© Have a look: www.thelancet.com/journals/ebi...
Full text open access link here: www.thelancet.com/journals/ebi...
Between 2006β2008, swine abattoir workers developed a nerve disorder linked to inhaled porcine neural tissue. ππ§ A new study identifies synaptophysin-IgG & GAP43-IgG as key biomarkers, also seen in non-exposed patients with a treatable inflammatory polyradiculoneuropathy
#autoimmunity #neuropathy
πβ¬οΈ
The December 2025 issue of eBioMedicine is now live!
On this monthβs cover:
π§ββοΈ The accelerating pace of ALS research
π¬ AI-driven immune profiling from histopathology slides to predict chemo-radiotherapy outcomes in rectal cancer
ποΈβοΈ Age and livability in a hotter climate
Promotional card. Contact Rida Ansari regarding content enquiries at rida.ansari@lancet.com. Copyright: Elsevier Ltd.
Senior Editor at eBioMedicine Rida Ansari (@ridaansari.bsky.social) is looking forward to attending @britishneuro.bsky.social #neuroscience Festive Symposium in London, and welcomes queries from attendees!
Learn more about our scope and global reach & impact here: hubs.li/Q03BLdg_0
Promotional card. Contact Rida Ansari regarding content enquiries at rida.ansari@lancet.com. Copyright: Elsevier Ltd.
Senior Editor at eBioMedicine, Rida Ansari (@ridaansari.bsky.social), is looking forward to attending @crick.ac.uk Translational Research Symposium in London, and welcomes queries from attendees!π‘π§ͺ
Learn more about our scope and global reach & impact here: hubs.li/Q03BLdg_0
A relatively new class of insecticide called βspatial emanatorsβ offer protection from mosquito-borne diseases such as malaria, dengue, West Nile, yellow fever, and Zika. This meta-analysis of more than 25 years of research provides clarity on how to test these products and how well they work.
Summary of main changes in CONSORT 2025. Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC BY 4.0
First published in 1996, the CONSORT statement was designed to improve the quality of reporting and provide a minimum set of items to be included in a report of a randomised trial.
Now, there is an updated 2025 Statement.
Find it here: tinyurl.com/2s3hv3yx
π NEW on schizophrenia: @cumedicengage.bsky.social researchers found links between π medication variables & cognitive ability & 𧬠pharmacogenomic variation with positive & negative symptom severity β¨. Based on dimensions from a CFA of validated questionnaires π§βπ»
Funding: @mhrukcharity.bsky.social
A set of chemicals found in food packaging, plastics, and lotions and shampoos has been linked to hundreds of thousands of deaths from heart disease, according to a study published Tuesday in the journal eBioMedicine.
Cover figure presenting main results from the paper. Left: altered spectral power and covariance difference between AD progressers and stable MCI patients. Right: multivariate analysis, highlighting the complementarity of MEG covariance spectra, MRI cortical volumes and baseline control measures.
π©Ίπ§ β¨Excited about our latest work published in @ebiomedicine.bsky.social! In the BioFIND dataset, we found that brain activity provided unique information about progression to Alzheimerβs Disease (AD). #neuroskyence Paper: www.thelancet.com/journals/ebi...; Thread 𧢠‡οΈ